To check counterfeit medications, the working group may vet a plan

To weed out the fake drugs from the market, India’ central drug regulator “The Central Drugs Standard Control Organization (CDSCO) “is making a working group to basically assess its proposition to set up a “trace and track” algorithm.

The working group, including pharmaceutical affiliation delegates and individuals from the Central Drugs Standard Control Organization, is to present their reports regarding the issues and “reasonable solutions” by October 2017 as a knowledgeable mind for the improvement.

This move takes speed after receiving the approval from the Drugs Technical Advisory Board on a ” trace and track” system in a meeting held on May 16. The proposal that passed included the addition of a 14-digit number to be imprinted on the names of the best 300 pharmaceutical brands unique to each strip and bottle sold in the market.

Once the system developed, patients will be going to have the ability to check whether the medicines are real through an instant message with that 14 digit code to a number gave on the names by organizations showcasing the medication.

A meeting chaired by the Drug Controller General of India on June 25 expressed that the significant targets are to create a fear in the brains of forgers and develop the clear picture of the Indian pharma industry. The presentation of this system put the workload on the regulatory agencies. CDSCO has no role in deciding the technology that will use for the system and the decision for the technology for authentication, technology provider, a service provider has to be decided by the pharmaceutical forum.

Amid the meeting, business delegates and contract producers raised worries over the expenses of working such a system expecting them to print unique codes on shortlisted brands. A few organizations that had just presented such a verification system said the number of individuals utilizing this system was “low.” “The idea is adequate on a fundamental level, subject to tending to the IT concerns, cost and operability,” one of the sources said.

Serialization would expand the cost for contract makers and make their business “unviable,” they said. MSME ventures looked for appropriations for the “extra cost” producers need to hold up under.

Related Posts

  • Pharma
  • July 24, 2025
  • 188 views
Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

Natco Pharma shares slipped 2.5% to Rs 1,009 apiece on the BSE in Thursday’s trade after the company announced its plan to acquire a 35.75% stake in South Africa-based Adcock…

  • Pharma
  • July 22, 2025
  • 271 views
DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

The Directorate General of Foreign Trade ( DGFT ) has notified an extension in the deadline for submitting applications for the export of Pharma Grade Sugar. This was communicated through Trade Notice…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra